(PharmaNewsWire.Com, January 22, 2018 ) According to Publisher, the Global Liquid Biopsy market is expected to grow from $310.0 million in 2016 to reach $1201.52 million by 2023 with a CAGR of 21.3%. Increasing research & developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. On the other hand, higher costs and complex regulations are restraining the market growth.
Liquid biopsy tests are used to help find cancer at an early stage. These tests are performed to interpret the molecular aspects of cancer across the healthcare and research settings, such as research laboratories, physicians, pathological and hospitals. The circulating tumor cells leads the market globally with the largest market share and is expected to grow with a highest CAGR during the forecast period. By cancer type, lung cancer segment is expected to witness high growth rate during the forecast period. North America emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S.
Some of the key players in global liquid biopsy market include Roche Diagnostics, Guardant Health, Inc, Illumina, Inc, Biocept, Inc, Myriad Genetics, Inc, Qiagen N.V. , Genomic Health, Inc Thermo Fisher Scientific Inc , Bio-Rad Laboratories, Inc, Epic Sciences, Exosome, Cynvenio Guardant Health, Personal Genome Diagnostics and Janssen Diagnostics, LLC.
End Users Covered: -Academic and Research Centers -Hospitals and Physician Laboratories -Diagnostic centres & Reference Laboratories
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -UK -Italy -France -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -South Korea -Rest of Asia Pacific -South America -Argentina -Brazil -Chile -Rest of South America -Middle East & Africa -Saudi Arabia -UAE -Qatar -South Africa -Rest of Middle East & Africa
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
